Author: CannabisNewsWire (CNW)

About CannabisNewsWire CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge. To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only) For more information please visit https://www.CannabisNewsWire.com Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsBreaks – Supreme Cannabis Company Inc. (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1) Reports Annual General Meeting of Shareholders Voting Results

Supreme Cannabis Company (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1), a global diversified portfolio of distinct businesses, products and brands, today announced detailed voting results from its 2020 Annual General Meeting of Shareholders that was held on November 9, 2020. Among other highlights, Michael La Brier, Beena Goldenberg, Jackie Poriadjian-Asch, Ronald Factor, Colin Moore and Kenneth R. McKinnon were elected to the company’s board of directors. The newly elected board members will serve until the next annual meeting of shareholders, or until their successors are elected or appointed. In addition, KPMG LLP were reappointed as auditors of the company to hold office until the next annual meeting, and the board is authorized to fix their remuneration. SPRWF filed a report detailing the results on all resolutions voted on at the meeting on www.sedar.com.

To view the full press release, visit https://cnw.fm/DSkKY

About Supreme Cannabis

The Supreme Cannabis Company is a global diversified portfolio of distinct cannabis companies, products and brands. Since 2014, the Company has emerged as one of the world’s most premium producers of recreational, wholesale and medical cannabis products.

Supreme Cannabis’ portfolio of brands caters to diverse consumer and patient experiences, with brands and products that address recreational, wellness, medical and new consumer preferences. The Company’s recreational brand portfolio includes 7ACRES , Blissco , 7ACRES Craft Collective , Sugarleaf and Hiway . Supreme Cannabis addresses national and international medical cannabis opportunities through its premium Truverra brand.

Supreme Cannabis’ brands are backed by a focused suite of world-class operating assets that serve key functions in the value chain, including scaled cultivation, value-add processing, automated packaging and product testing and R&D. Follow the Company on Instagram , Twitter , Facebook  and YouTube . For more information, visit the company’s website at www.Supreme.ca.

NOTE TO INVESTORS: The latest news and updates relating to SPRWF are available in the company’s newsroom at http://cnw.fm/FIRE

About CanadianCannabisWire

CanadianCannabisWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CanadianCannabisWire.com

Please see full terms of use and disclaimers on the CanadianCannabisWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CanadianCannabisWire (CNW)
Toronto, Ontario
www.CanadianCannabisWire.com
905.674.5977 Office
Editor@CanadianCannabisWire.com

420 with CNW — CBD Shampoo Alleviates Symptoms of Scalp Inflammation

For the past couple of years, cannabidiol (“CBD”) has held the world’s attention. Extracted from industrial hemp, a nonpsychoactive variety of cannabis, CBD is brimming with potent medicinal properties. Anecdotal evidence and preliminary research have found it effective against a host of medical conditions including anxiety, insomnia, post-traumatic stress disorder (“PTSD”) and pain.

According to a team of researchers from Italy and the United States, cannabidiol may also offer relief against scalp inflammation. Also known as scalp dermatitis, inflammation of the scalp usually results in flaky, itchy and painful patches. It is often caused by scalp psoriasis and seborrheic dermatitis. Dr. Shani Francis, a board-certified dermatologist who specializes in hair loss and the chief wellness officer of Ashira Dermatology, says that “scalp dermatitis is a very broad condition, and it has multiple diagnoses which are very common, as well as some rare ones.”

Save for a few instances, scalp inflammation isn’t a serious condition, and it can usually be treated with either topical treatments or over-the-counter medications. When researchers from Italy and the United States recently teamed up to explore the efficacy of cannabis-based shampoos on patients who suffer from scalp inflammation caused by scalp psoriasis or seborrheic dermatitis, the results were encouraging. The team found that cannabidiol has potent anti-inflammatory properties, making it a suitable treatment against a condition caused by inflammation, at least on paper.

They evaluated the “efficacy of a shampoo containing 0.075% broad-spectrum cannabidiol in 50 subjects with mild to moderate scalp psoriasis or seborrheic dermatitis,” the study authors note. At the end of the study, the researchers found that the CBD shampoo provided noticeable relief to study participants after only two weeks of use.

The researchers measured inflammation by evaluating how dense the twisted/glomerular or arborizing vessels were. They relied on trichoscopy using a six-point scale at baseline and day 14. Several symptoms, including itching or burning sensations, erythema/scaling, overall tolerability, as well as subject satisfaction were evaluated.

New York dermatologist Matthew Lin, MD, states that the endocannabinoid system works with CBD to reduce the symptoms of scalp inflammation. It acts on the cannabinoid receptors and reduces what are known as inflammatory cytokines within the scalp. Using a CBD shampoo could improve eczema, dandruff, and seborrheic dermatitis as well as an itchy, flaky scalp.

This lines up with what the team of researchers concluded at the end of the study. Changing the current shampooing practices and taking up a shampoo containing CBD can significantly reduce both the severity and the symptoms of scalp inflammation in approximately two weeks, with the added bonus of high tolerability and treatment satisfaction in people with mild or moderate scalp psoriasis or even seborrheic dermatitis.”

Sugarmade Inc. (OTCQB: SGMD) is a company you should watch in the cannabis sector. The firm specializes in offering delivery services to cannabis businesses, and SGMD has recently ramped up its plans to start marijuana cultivation.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

HempFusion Wellness Inc. Is ‘One to Watch’

  • HempFusion’s current product offerings, already available in stores, include tinctures, capsules, OTC topicals, edibles, probiotics and a doctor/practitioner line
  • The company abides by all FDA regulations for its full line of products. It is one of few companies marketing FDA Drug Listed Topicals
  • HempFusion is currently one of 12 CBD companies conducting a study addressing FDA concerns regarding CBD products and human safety
  • The significant time and capital invested in HempFusion’s compliance provide the company with a competitive advantage in the expanding CBD market
  • The CBD sector is projected to reach $16.8 billion by 2025
  • The company has the second-largest cash presence in the market at $18.3 million as of June 30, 2020, and it is preparing to launch an IPO and list on the Toronto Stock Exchange under ticker symbol ‘CBD.U’

HempFusion Wellness is a leader in the health and wellness CBD industry, providing innovative and diversified proprietary formulations utilizing the power of whole-food hemp nutrition.

Invested heavily in regulatory compliance, HempFusion aims to consistently meet and even exceed the high standards required by retailers and consumers – putting safety, quality and consistency first. In support of these efforts, the company is U.S. Hemp Authority Certified and is a current board member of the U.S. Hemp Roundtable, a coalition of leading companies committed to advancing safe hemp and CBD products.

HempFusion reported 1,750 shareholders and $18.3 million in cash as of June 30, 2020 – the second-largest cash position in its sector – with no debt. Looking ahead, the company is currently preparing to launch an IPO directly onto the Toronto Stock Exchange (“TSX”) senior board, where it has already reserved ticker symbol ‘CBD.U’. Learn More About HempFusion Upcoming IPO.

HempFusion is headquartered in Denver, Colorado.

HempFusion’s Proprietary Wellness Portfolio

The diverse product portfolio showcased by HempFusion includes 46 products that are currently on shelves. The company’s leading offerings include HempFusion-owned Biome Labs, HF Labs and Probulin. Due to the time and resources allocated to increasing the compliance of these proprietary products, HempFusion may have a competitive advantage and create additional retail opportunities that are not available for other CBD companies.

HempFusion’s Diversified Revenue Pipeline

HempFusion’s focus and investment into regulatory compliance has opened doors to major food and drug mass or big box retailers that are not available to other CBD companies. This strategic approach includes five distinct channels:

  • Natural Health Retailers
  • eCommerce
  • Big Box / Food and Drug Mass
  • Doctor Practitioner
  • Convenience

HempFusion’s Line of Products

HempFusion’s branded line of products is based on the company’s proprietary Whole Food Panoramic Full-Spectrum Hemp Complex. Each product is condition-specific, targeting needs such as sleep, energy and stress.

All of HempFusion’s products are made from DNA-verified, European Union registered, non-GMO, organic industrial hemp. The company’s offerings span multiple product categories, including:

  • Tinctures and capsules – These offerings make up the most popular product category in the $4 billion U.S. CBD market.
  • OTC topicals – HempFusion is one of the few CBD companies marketing FDA Drug Listed Topicals. The FDA compliance standards ensure that these products meet the standards set by larger national retailers.
  • Condition-specific OTC products – HempFusion has OTC products that are condition-specifically targeted, including:
  • OTC Pain Products – The global pain relief market for topicals is projected to reach $13.3 billion by 2025, with a CAGR from 2018 to 2025 of 7.4%.
  • OTC Eczema Products – The global dermatitis market is projected to reach $13.6 billion by 2026.
  • OTC Acne and Aging/Beauty Products – The global market for beauty and anti-aging products is currently estimated at $1.08 trillion.
  • OTC First Aid and Wound Healing Products – In 2019, the 10 top-selling first aid ointments in the United States generated over $650 million in sales.

Probulin Probiotics and Digestive Enzymes

Probulin Probiotics is a 100% wholly owned subsidiary of HempFusion Wellness Inc. and is currently one of the fastest growing probiotics brands in the United States, according to Spins syndicated data.

The Probulin product line addresses a wide range of consumer needs, including daily care, total care, women’s health and children’s products. The probiotics market represents a growing opportunity, as it is estimated to reach $7 billion globally by 2022.

Because of the diverse offerings of the Probulin line, it serves as HempFusion’s gateway to retailers who may not currently carry CBD products.

This ‘Trojan Horse Strategy’ is intended to allow the company to establish, develop and build relationships among these retailers. By achieving approved vendor status, the company may be able to facilitate faster onboarding times, enabling accelerated access to its CBD products in the future.

HF Labs and Biome Research – Doctor and Practitioner Product Lines

The HF Labs and Biome Research product lines are directed toward doctors and practitioners and cater to hospitals, compounding pharmacies and free-standing dispensaries. With an estimated target market of 28,000+ integrative medical doctors and 70,000+ licensed chiropractors in the United States, these offerings create a unique market opportunity as HempFusion continues to broaden its footprint in the CBD industry.

Research on CBD and Human Safety

HempFusion is one of 12 CBD companies selected to participate in ValidCare’s groundbreaking study regarding CBD and human safety, which is expected to be complete by the end of October 2020. The study is designed to address previous questions from the FDA regarding CBD products.

As part of this study, HempFusion and the other selected companies will be conducting human trials to determine if the daily use of full-spectrum hemp-derived CBD or CBD isolate impacts the human liver.

Management Team

Jason Mitchell, N.D., is the co-founder, Director and CEO of HempFusion. He has over 20 years of experience in the natural products industry and is a naturopathic doctor certified by the ANMCB. Mitchell received his doctorate from the Trinity College of Natural Health and is a member of the American Naturopathic Medical Association and the CNHP. He is an expert in supplemental formations and was responsible for successfully creating and launching over 300 industry-leading products during his 15-year tenure at Country Life Vitamins.

Ian DeQueiroz is the Chief of Brand Strategy & Partnerships and a Director for HempFusion. He is a serial entrepreneur with experience in early-stage cannabis and hemp companies. In 2010, he acquired his first cannabis CO2 extraction company in the United States. DeQueiroz has facilitated the licensing process for many companies in the United States, as well as one of Jamaica’s premier cannabis companies, Epican Medicinals Ltd.

Jon Visser is HempFusion’s Chief Revenue Officer. He has over 25 years of experience in all areas of sales and marketing, with a proven track record of consistently driving growth across all major channels. Visser was previously the Senior Vice President of Sales at Navajo Inc., a multi-national manufacturer/distributor of brands like Pennzoil Automotive Supplies, Piranha Eyewear and Navajo Inc., the largest distributor of trial- and travel-sized health and beauty products in the United States. Visser grew annual sales from $60 million to $128 million in less than three years while at Navajo Inc.

Bruce Valentine Jr. is the Chief Financial Officer of HempFusion. He has a proven track record working with high-growth companies and was named CFO of the Year in 2013 by the Northern Colorado Business Report. Valentine is the former CFO of Otter Products and has over 15 years of financial management experience.

Ola Lessard is the Chief Marketing Officer of HempFusion and is also the President of the U.S. Hemp Roundtable. She has experience in marketing creative and effective brand strategies. She is a former Vice President of Marketing at Barlean’s, an award-winning supplements provider based in Washington.

Nancy Angelini is the Director of the Doctor/Practitioner Channel. She has over 25 years as an active, licensed practitioner. Angelini travels the country as a lecturer and product manager. She is responsible for opening doors to some of the largest doctor/practitioner networks in the United States.

Daniel Brody is the Chief Corporate Officer of HempFusion. He is the co-founder and former Vice President of The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF). Brody has been instrumental in listing multiple world-class cannabis companies, including TGOD, Emblem Corp. and Plus Products Inc. (CSE: PLUS) (OTCQX: PLPRF). Before joining the cannabis industry, he spent seven years working at two leading Canadian brokerage firms.

For more information, visit the company’s website at www.HempFusion.com.

NOTE TO INVESTORS: The latest news and updates relating to HempFusion are available in the company’s newsroom at https://cnw.fm/HempFusion

About HempWire

HempWire (HW) is a dedicated information provider focused on (1) aggregating hemp-related news, (2) issuing HempNewsBreaks designed to update investors on the latest developments in the hemp market, (3) enhancing corporate news releases, (4) providing full-service distribution and social media offerings to public and private client-partners and (5) designing and implementing all-inclusive corporate communication solutions. HW is strategically positioned within the rapidly expanding hemp sector with a team of journalists working to help a growing roster of public and private companies reach a wide audience of investors, consumers and members of the media. We leverage a vast network of more than 5,000 key syndication outlets to deliver unparalleled visibility, recognition and content to the hemp industry. HempWire (HW) is where HEMP news, content and information converge.

To receive instant SMS alerts, text HEMPWIRE to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.HempWire.com

Please see full terms of use and disclaimers on the HempWire website applicable to all content provided by HW, wherever published or re-published: https://www.HempWire.com/Disclaimer

Do you have a questions or are you interested in working with HW? Ask our Editor

HempWire (HW)
Denver, Colorado
www.HempWire.com
303.498.7722 Office
Editor@HempWire.net

HempWire is part of the InvestorBrandNetwork.

420 with CNW — Will Europe Increase Its THC Limit to 0.3%?

In late October, the European Parliament voted to raise the THC limit for industrial hemp from 0.2% to 0.3%. Back in 1984, the standard for a European THC limit in industrial hemp was set at 0.5%. That limit was reduced to 0.3% in the 1970s and reduced even further to 0.2% in 1999. The original goal of the 0.2% limit was to prevent high-THC marijuana from being grown in low-THC industrial hemp fields.

However, in the 20 years since the limit was set, hemp farmers in Europe have been pushing for it to be raised, arguing that the limit reduces the number of strains they can use. Amendment 8 & 93, which raises the limit state, “As regards the areas used for the production of hemp, in order to preserve public health and to ensure the coherence with other bodies of legislation, the use of hemp seeds varieties with tetrahydrocannabinol content below 0.3% should be part of the definition of eligible hectare.”

These amendments were passed alongside Amendment 234, which adds hemp to the sectors covered by EU marketing standards so that eventually products could be graded according to appearance, consistency, characteristics and restrictions. Parliament’s vote to increase the limit to 0.3%, bringing it in line with the THC limits used in the Americas, has been met with applause from hemp activists.

“The increase of THC level would allow new varieties to enter the market and to be bred, resulting in a better adaptation of the crops to the climatic conditions of the different EU territories,” the European Industrial Hemp Association said in a statement.

Now that the European Parliament has approved the amendment increasing the THC limit to 0.3%, a few more steps are required before that legislation can take effect. Although advocates and players in the hemp industry have met the news with praise, some wonder whether the amendment will actually become effective. Parliament’s vote only establishes its opinion on the Common Agricultural Policy Reform proposal. For the amendment to actually go into effect, it has to be approved by two more bodies: The Council of the European Union and the European Commission.

These three bodies are set to begin negotiations on the agricultural policies in mid-November, only a couple of weeks away. At this point, any outcome is possible.

One interesting company you should watch in the cannabis sector is Pure Extracts Technologies Corp. (CSE: PULL). The firm focuses on extracting plant compounds, especially marijuana compounds. Recently the company added a new functional mushrooms vertical to its operations.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

Sugarmade Inc. (SGMD) Reports BudCars Q3 Numbers, Company Continues to Post Record Sales

  • SGMD releases key numbers for BudCars Q3 2020 financial report
  • CEO reports that company “continues to perform, setting records in basically every key metric we track”
  • BudCars has seen consistent growth since Sugarmade acquired 40% stake in the Sacramento-based cannabis delivery service

Steadily growing gross margins, more than 60% growth and $2 million in gross receipts are a few of the highlights in an announcement (https://cnw.fm/SLg0m) made by Sugarmade (OTCQB: SGMD) featuring the Q3 2020 numbers for BudCars Cannabis Delivery Service. SGMD owns a 40% stake in BudCars, along with an option to acquire an additional 30%.

“BudCars continues to perform, setting records in basically every key metric we track,” said Sugarmade CEO Jimmy Chan. “It was a tremendous quarter, with a big jump in customers and regional market share and robust margins on every sale. That paints a very motivating picture as we gear up to significantly expand our service territory, with upcoming expansion into the North Bay and Wine Country areas, as well as our upcoming grand opening of BudCars LA.”

The preannouncement of BudCars’ performance for the three months ended Sept. 30, 2020, included the following key numbers:

  • Total Q3 2020 BudCars gross receipts over $1.9 million, which represents a 66% increase quarter over quarter
  • Total Q3 BudCars gross profits of $903,667, representing 64% gross profit growth quarter over quarter on a steady 47% gross profit margins
  • Average daily gross sales increased $21,246, a 68% increase quarter to quarter
  • Total customer tickets increased 62% quarter to quarter on 3% growth in average ticket size

BudCars has seen consistent growth since Sugarmade acquired a 40% stake in the Sacramento-based cannabis delivery service earlier this year (https://cnw.fm/gTCbW). In fact, the company has performed ahead of expectations almost every month since March 2020, seeing consistent growth in almost every area, including increasing new customers, strong repeat business, increasing orders per customer per period, and increasing ticket sizes.

BudCars isn’t the only bright spot on the Sugarmade horizon. The company also recently secured rights to a property zoned for cannabis cultivation (https://cnw.fm/eAiph). The company is already in the process of obtaining cannabis cultivation licensing, preparing archaeological and biological surveys, and assembling documentation related to the architectural and engineering plans for construction of greenhouses and a processing building.

“We believe we have all of the strategic pieces in place to capitalize on cultivation, with the market currently chronically undersupplied,” said Chan. “We also have relationships in place, especially through our BudCars investment, to hit the ground running on the branded products side, driving strong margins up and down the chain.”

BudCars is a retail business that offers same-day delivery of top-quality cannabis. Customers choose from a variety of products including edibles, flower, pre-rolls, vapes, tinctures and concentrate across dozens of premium brands. Once consumers complete their purchases online, they receive their order the same day via BudCars Cannabis Delivery Service.

Sugarmade is a product and branding marketing company investing in operations and technologies with disruptive potential. The company’s brand portfolio includes CarryOutsupplies.com, SugarRush(TM) and Budcars.com. Sugarmade is an investor in BudCars and a joint operator of BudCars’ first operating location in Sacramento, California.

During early 2020, Sugarmade gained a 40% stake in BudCars and in the Sacramento delivery operations via the acquisition of a 40% stake in Indigo Dye Group (Indigo). Under the terms of Sugarmade’s agreement with Indigo, Sugarmade also acquired an option to purchase an additional 30% interest in Indigo, upon the closing of which would provide Sugarmade with a 70% controlling interest. As of the date hereof, this option has not yet been exercised; Sugarmade’s stake in Indigo remains at 40%, and there is no assurance that Sugarmade will exercise the option to acquire an additional 30% interest in Indigo.

However, since late May 2020, Sugarmade has been actively involved in development of Indigo’s operations with power to direct the activities and significantly impact Indigo’s economic performance. Sugarmade also has obligations to absorb losses and right to receive benefits from Indigo. As such, in accordance with the Financial Accounting Standards Board’s Accounting Standards Codification 810-10-25-38A through 25-38J, Indigo is considered a variable interest entity (“VIE”) of Sugarmade.

For more information, visit the company’s website at www.Sugarmade.com.

NOTE TO INVESTORS:: The latest news and updates relating to SGMD are available in the company’s newsroom at http://cnw.fm/SUGAR

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

CBDNewsBreaks – Jupiter Wellness Inc. (NASDAQ: JUPW) Secures Exclusive Distribution Agreement for Entire Florida Market

Jupiter Wellness (NASDAQ: JUPW), a cutting-edge wellness brand dedicated to providing multiple therapeutic and medical uses of cannabidiol (“CBD”), today announced its entry into an exclusive distribution agreement for Safe Sea(R) products. According to the update, the initial phase of the agreement is through the end of 2021 and covers all of Florida. Safe Sea develops, markets and distributes the world’s first sunscreen that provides protection from jellyfish stings and sea lice. “Our mission has always been to develop, market and sell the highest quality skin care and sun care products on the market;” Jupiter Wellness CEO Brian John said in the news release. “A distribution agreement with Safe Sea, while not related to our proprietary line of CBD infused sun care products, fits squarely within our larger mission and may open the door to further collaboration and product development down the road with other innovative companies in the space. In addition, it allows us to further monetize our existing sun care distribution network.”

To view the full press release, visit https://cnw.fm/KHCaG

About Jupiter Wellness Inc.

Jupiter Wellness is a leading, cutting-edge wellness brand dedicated to exploring the multiple therapeutic and medical uses of cannabidiol via a collection of convenient products and services not found anywhere else in the industry. It is dedicated to advancing research into the multitude of medical and therapeutic uses of CBD for treatment of common ailments like eczema, dermatitis, burns and herpes, among others. The company was formed in 2019 by a collection of professionals from the pharmaceutical, biotech and financial industries, and is headquartered in Jupiter, Florida. For more information, visit the company’s website at www.JupiterWellnessInc.com.

NOTE TO INVESTORS: The latest news and updates relating to JUPW are available in the company’s newsroom at https://cnw.fm/JUPW

About CBDWire

CBDWire (CBDW) is a specialized information provider focused on (1) reporting CBD-related news and updates, (2) releasing CBDNewsBreaks crafted to keep investors abreast of the latest and greatest in the CBD market, (3) refining and enhancing corporate press releases, (4) delivering end-to-end distribution and social media services to client-partners and (5) constructing effective corporate communication solutions based on the unique requirements of CBD companies. CBDW is exclusively positioned in the burgeoning CBD sector with a proven team of journalists and researchers working to deliver high quality content to an expansive target audience of investors, consumers and industry news outlets. Our dissemination network of over 5,000 downstream distribution points allows us to deliver unparalleled reach, visibility and recognition to companies operating in both cannabidiol and the wider cannabis space. CBDWire (CBDW) is where CBD news, content and information converge.

To receive instant SMS alerts, text CBDWire to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CBDWire.com

Please see full terms of use and disclaimers on the CBDWire website applicable to all content provided by CBDW, wherever published or re-published: https://CBDWire.com/Disclaimer

Do you have questions or are you interested in working with CNW? Ask Our Editor

CBDWire (CBDW)
Denver, Colorado
www.CBDWire.com
303.498.7722 Office
Editor@CBDWire.com

CBDWire is part of the InvestorBrandNetwork.

CannabisNewsBreaks – Cannabis Global Inc. (CBGL), NPE to Accelerate Expansion Plan Based on Expected Nationwide Cannabis Legalization

Cannabis Global (OTC: CBGL), a science-forward company developing CBD infusion technologies and products while investing in fast-growing segments of the cannabis industry, today announced an acceleration of its plans to expand operations in the cannabis sector in reaction to the significantly improved prospects for nationwide legalization of cannabis. According to the update, the strategic expansion will be conducted with Natural Plant Extract of California Inc (“NPE”). Cannabis Global recently acquired an 18.8% strategic investment stake in NPE, which holds a special Type 7 California cannabis manufacturing license, allowing for volatile extraction methodologies and cannabis product distribution anywhere in the state. “We are already seeing rapid expansion of cannabis legalization across the United States, with last week multiple states voting to legalize. With a new Biden Administration, we believe the winds of change toward probable federal de-scheduling and legalization are accelerating,” said CBGL CEO Arman Tabatabaei. “With a combination of our growing intellectual property portfolio and the continued expansion of our relationship in the licensed cannabis segment with NPE, nationwide cannabis legalization creates expanding opportunities for our company.”

To view the full press release, visit https://cnw.fm/TfMQD

About Cannabis Global Inc.

Cannabis Global, formerly known as MCTC Holdings Inc., is a fully audited and reporting company with the U.S. Securities & Exchange Commission, trading with the stock symbol CBGL. The company is an emerging force in cannabinoid sciences and highly bioavailable hemp and cannabis infusion technologies. Cannabis Global has an actively growing portfolio of cannabis investments and intellectual property, having filed six provisional patents relative to the areas of cannabinoid delivery systems and cannabinoid polymeric nanoparticles. The company markets its consumer products under the Hemp You Can Feel(TM) brand name. Cannabis Global launched its Project Varin early in 2020 to develop new delivery methods for rare cannabinoid tetrahydrocannabivarin (“THV-C”) and develop products based on this cannabinoid. For more information, visit the company’s website at www.CannabisGlobalInc.com.

NOTE TO INVESTORS: The latest news and updates relating to MCTC are available in the company’s newsroom at http://cnw.fm/CBGL

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

420 with CNW — State Reveals Stores Have Sold Marijuana Products Valued at Half a Billion Dollars

For the sixth consecutive month, Illinois has crushed yet another cannabis sales record, having reached a $500-million-worth benchmark of legal marijuana products that have been bought since the program was launched at the start of this year. Illinois has shown that its marijuana market is not only pandemic proof but also recession proof.

Last month, adults bought 1,557,880 cannabis products worth $75,278,200 cumulatively. That’s almost $8 million more than sales in September and about twice the sales recorded in January. These figures do not include purchases made through the state’s medical marijuana program. Based on this, to say the strides made in the market weren’t in the least impressive would be a blatant lie.

It is estimated that about $21 million of these recorded sales came from out-of-state tourists while roughly $55 million in purchases came from in-state residents. In addition, state officials announced in October that the state had surpassed $100 million in revenue due to the high sales. The revenue is being used to fund restorative justice programs and local governments.

Illinois state officials stated that the tax revenue from the market will be reinvested in communities that have been most affected by the drug war. Almost 25% of the tax revenue collected has been designated for restorative justice grants, and other funds will be used to support mental health and substance misuse treatment programs. In May, the state had announced that it would be making nearly $31 million in social equity grants available to communities that had been identified as economically distressed.

Additionally, before the state implemented its cannabis system, Illinois Gov. J.B. Pritzker pardoned more than 11,000 individuals with prior marijuana convictions. The governor also revealed in October that he would be granting more acts of cannabis clemency in the coming months. Amid the coronavirus pandemic, the recent sales numbers also strengthen the argument made by pro-reform lawmakers in various states.

However, not all parties are excited about this increase in sales. An alliance of state medical societies released a joint statement last week that criticized the efforts to legalize cannabis. These statements noted that the various societies appreciated the economic challenges states face as a result of the coronavirus pandemic but urged against legalization of cannabis as a way to address these challenges.

This is despite the fact that South Dakota, Oregon, New Jersey, Montana, Arizona and Mississippi have approved various measures that legalize cannabis in their states during this week’s elections.

The Alkaline Water Company Inc. (NASDAQ: WTER) (CSE: WTER) is one cannabis sector player you should watch. The company started out providing premium alkaline water, and it has now set its sights on adding topical and ingestible hemp-infused products to its portfolio.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW — 5 Mistakes You Should Avoid While Making Cannabis Gummies

Although quite young, the market for cannabinoid-infused products is swiftly growing. Consumers have especially taken a liking to gummies infused with cannabidiol (“CBD”) and THC, the most prominent cannabinoids. According to Google, CBD gummies were the third most searched food by Americans in 2018. All in all, the global market for CBD gummies is expected to register a compound annual growth rate of 31.9% by 2025.

However, creating cannabinoid-infused gummies that consistently sell is no easy task, and one single mistake could leave you with a batch of gummies no one wants to buy. So, as you work to develop your cannabinoid-infused gummies, make sure to avoid the following mistakes;

Sacrificing flavor for potency. Cannabinoids such as THC and CBD have a naturally bitter, hemp-like taste, and at potency ratios above 2 to 3 milligrams of cannabinoid per one gram of gummy, the taste becomes difficult to mask. Since we’re dealing with confectionaries, taste matters a whole lot, and customers will be put off by a gummy that tastes bitter. Going for a super potent recipe will likely result in a potent but bitter product that won’t see many sales.

Lacking consistency, especially when it comes to potency. A lot of people use CBD and THC products for specific reasons, such as pain relief or to improve sleep. If the potency of your gummies doesn’t remain consistent, your customers will not have the same experience every time they buy — and use — your products. Even if they aren’t using it to address a health issue, they will undoubtedly be put off by the lack of consistency in potency.

Not understanding how the ingredients interact. A typical gummy consists of about 80% sugar and corn syrup, 2–8% gelling agent (starch, gelatin or pectin), and less than 1% flavor, acid and color. Gelatin is an easier gelling agent to work with, allowing for a firm, almost transparent gummy. On the other hand, pectin is vegetarian, and sellers who lean in that direction prefer it. However, pectin is harder to work with, sn’t thermally reversible and can ruin a batch of gummies when a mistake is made. Having a thorough grasp of how all the ingredients work together right from the start will save you a lot of time and money.

Not using the right tools. You will need specialized equipment such as a refractometer and a water activity meter to produce high-quality gummies and jellies. Such tools are used to measure the sugar content of the gummy syrup and the water activity respectively, factors that contribute greatly to the quality of your final product.

Improper Curing. Depending on factors such as the type of mold (silicon or starch), the formula, the temperature, and relative humidity of the room, it can take anywhere from 24 to 48 hours for the gel to set and dehydrate. Understanding the proper curing requirements for your specific formula and location will allow you to create the perfect conditions for the gel to set and dehydrate perfectly.

A company you should watch in the marijuana space is Sugarmade Inc. (OTCQB: SGMD). The company specializes in offering delivery services both in the cannabis industry and the quick-service restaurant sector, and the current pandemic has highlighted how valuable such services are.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW — Maine Medical Cannabis Dispensary Chain Applies to Join Residency Court Case

Last week, Wellness Connection filed a motion to protest a lawsuit against the state of Maine, which was launched by two small marijuana businesses over recreational marijuana licenses that were awarded to out-of-state firms.

Wellness Connection, which is controlled by Delaware-based investor High Street Capital Partners, manages four medical marijuana dispensaries in Maine. The recreational marijuana market in Maine is relatively new, having launched on October 9 of this year. Despite its youth, the market is expected to soon eclipse the medical cannabis market size, with total sales projected to be $76 million this year; adult-use cannabis sales making up $20 million of that amount.

By 2025, it is projected that sales will grow almost four times as high, to $295 million, with adult-use marijuana sales dominating the market sales with $265 million. The cannabis business also promoted the growth of cottage industries such as tourism.

Earlier in March, Wellness Connection sued the state of Maine over a legislation that restricted cannabis businesses with out-of-state owners from participating in the adult-use market. The company dropped the case, however, after the state confirmed that it would not be enforcing the law, which required every manager, director or officer of an adult-use marijuana business to be a resident of Maine and file taxes in the state for at least a four-year period. The state gave the reason that the residency requirement would not hold up in court.

The new motion was filed by the company on behalf of its adult-use business, NPG, in a bid to get the lawsuit of the two medical cannabis caregivers thrown out of court. The caregivers claim that the state cannot decline to enforce the law that restricts out-of-state business owners from setting up shop in the state. This is despite the state eliminating the residency requirement in May of this year.

The new motion puts the state and Wellness Connection on the same side as defendants, which is ironic. The company is currently working on converting its medical cannabis business into an adult-use cannabis business, as its executives believe the latter is more lucrative.

In its earlier lawsuit, Wellness Connection claimed that the requirement hindered the company from raising the funds that would facilitate the transition. Currently, NPG holds an active cultivation license for adult-use cannabis, an active manufacturing license and an additional five conditional approvals for four dispensaries and another manufacturing facility.

One interesting cannabis industry sector player you should watch is Pac Roots Cannabis Corp. (CSE: PACR). This company selectively breeds high-end strains of cannabis in order to make premium products for the Canadian market and its international partners.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.